Clinical efficacy and tolerability of extended‐release tolterodine and immediate‐release oxybutynin in Japanese and Korean patients with an overactive bladder: a randomized, placebo‐controlled trial

To compare extended‐release (ER) tolterodine and immediate‐release (IR) oxybutynin with placebo in Japanese and Korean patients with an overactive bladder (OAB).

[1]  R. Dmochowski,et al.  Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial. , 2003, Mayo Clinic proceedings.

[2]  M. Choo,et al.  Tolterodine: As effective but better tolerated than oxybutynin in Asian patients with symptoms of overactive bladder , 2002, International journal of urology : official journal of the Japanese Urological Association.

[3]  Magnus Fall,et al.  The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. , 2003, Urology.

[4]  D. Sussman,et al.  Treatment of Overactive Bladder with Once-daily Extended-release Tolterodine or Oxybutynin: The Antimuscarinic Clinical Effectiveness Trial (ACET) , 2002, Current medical research and opinion.

[5]  C. Chapple,et al.  Tolterodine: Selectivity for the Urinary Bladder Over the Eye (as Measured by Visual Accommodation) in Healthy Volunteers , 2002, Drugs in R&D.

[6]  A. Wein,et al.  Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review. , 2002, European urology.

[7]  R. Lipton,et al.  Health-related quality of life among adults with symptoms of overactive bladder: results from a U.S. community-based survey. , 2001, Urology.

[8]  B. Shaffu,et al.  Tolterodine: superior tolerability than and comparable efficacy to oxybutynin in individuals 50 years old or older with overactive bladder: a randomized controlled trial. , 2001, The Journal of urology.

[9]  A. Wein,et al.  Tolterodine once-daily: superior efficacy and tolerability in the treatment of the overactive bladder. , 2001, Urology.

[10]  M. Lapitan,et al.  The Epidemiology of Overactive Bladder among Females in Asia: A Questionnaire Survey , 2001, International Urogynecology Journal.

[11]  Franke Jj,et al.  Treatment of elderly women with urge incontinence in middle tennessee: a single institution practice-based study. , 2000 .

[12]  C. Kelleher,et al.  Overactive bladder significantly affects quality of life. , 2000, The American journal of managed care.

[13]  S. Kageyama,et al.  Urinary incontinence among community‐dwelling people aged 40 years or older in Japan: Prevalence, risk factors, knowledge and self‐perception , 2000, International journal of urology : official journal of the Japanese Urological Association.

[14]  D. Grossklaus,et al.  Treatment of elderly women with urge incontinence in middle tennessee: a single institution practice-based study. , 2000, Tennessee medicine : journal of the Tennessee Medical Association.

[15]  H. Nakano,et al.  Urinary Incontinence in Women Seen in the Obstetrics and Gynecology Clinic , 2000, International Urogynecology Journal.

[16]  T. Ushiroyama,et al.  Prevalence, incidence, and awareness in the treatment of menopausal urinary incontinence. , 1999, Maturitas.

[17]  Kirchberger,et al.  Quality‐of‐life aspects of the overactive bladder and the effect of treatment with tolterodine , 1999, BJU international.

[18]  P. Patsalos.  The mechanism of action of topiramate , 1999 .

[19]  S. Radomski,et al.  Clinical Efficacy and Safety of Tolterodine Compared to Oxybutynin and Placebo in Patients with Overactive Bladder , 1999, International Urogynecology Journal.

[20]  P. Abrams,et al.  Tolterodine, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder. , 1998, British journal of urology.

[21]  J. Duckett,et al.  A medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance , 1997, British journal of obstetrics and gynaecology.

[22]  L. Cardozo,et al.  A medium term analysis of the subjective efficacy of treatment for women with detrusor instability and low bladder compliance , 1997, British journal of obstetrics and gynaecology.